Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products (English, HTML)

View metadata and access the original English HTML file: Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-07

Health Canada initiated a Hormone Replacement Therapy (HRT) class labelling project in light of new safety information derived from the results of the Women's Health Initiative (WHI) trial and the Women's Health Initiative Memory Study (WHIMS). This document is intended to help the pharmaceutical industry revise the content of the Product Monograph and associated labelling materials.

Access original file